---
input_text: D-penicillamine and plasmapheresis in acute liver failure secondary to
  Wilson's disease. We report a case of a 19-year-old woman with acute liver failure,
  Coombs negative hemolytic anemia, and renal failure as initial manifestations of
  Wilson disease with recovery following medical treatment. The clinical picture and
  low serum transaminase and alkaline phosphatase levels gave us a clue to suspect
  Wilson disease and to initiate plasmapheresis and D-penicillamine soon after admission.
  The serum and urinary copper levels were elevated with low serum ceruloplasmin.
  We proceeded to ambulatory follow-up with medical treatment with D-penicillamine.
  A few months later, during the course of a laparoscopic cholecystectomy because
  of symptomatic gallstone disease, a liver biopsy sample was obtained that showed
  histological liver fibrosis and strongly elevated levels of liver tissue copper.
raw_completion_output: |-
  primary_disease: Wilson's disease

  medical_actions: plasmapheresis; D-penicillamine treatment; ambulatory follow-up; laparoscopic cholecystectomy

  symptoms: acute liver failure; Coombs negative hemolytic anemia; renal failure; low serum transaminase levels; low alkaline phosphatase levels; elevated serum and urinary copper levels; low serum ceruloplasmin; histological liver fibrosis

  chemicals: D-penicillamine; copper

  action_annotation_relationships: plasmapheresis TREATS acute liver failure IN Wilson's disease; D-penicillamine treatment TREATS acute liver failure IN Wilson's disease; D-penicillamine treatment TREATS Coombs negative hemolytic anemia IN Wilson's disease; D-penicillamine treatment TREATS renal failure IN Wilson's disease; ambulatory follow-up TREATS Wilson's disease; laparoscopic cholecystectomy PREVENTS symptomatic gallstone disease IN Wilson's disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  laparoscopic cholecystectomy PREVENTS symptomatic gallstone disease IN Wilson's disease

  ===

extracted_object:
  primary_disease: MONDO:0010200
  medical_actions:
    - plasmapheresis
    - D-penicillamine treatment
    - ambulatory follow-up
    - laparoscopic cholecystectomy
  symptoms:
    - HP:0006554
    - Coombs negative hemolytic anemia
    - HP:0000083
    - low serum transaminase levels
    - low alkaline phosphatase levels
    - elevated serum and urinary copper levels
    - low serum ceruloplasmin
    - histological liver fibrosis
  chemicals:
    - CHEBI:7959
    - CHEBI:28694
  action_annotation_relationships:
    - subject: plasmapheresis
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
    - subject: treatment
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
      subject_extension: CHEBI:7959
    - subject: treatment
      predicate: TREATS
      object: Coombs negative hemolytic anemia
      qualifier: MONDO:0010200
      subject_extension: CHEBI:7959
    - subject: treatment
      predicate: TREATS
      object: HP:0000083
      qualifier: MONDO:0010200
      subject_extension: CHEBI:7959
    - subject: ambulatory follow-up
      predicate: TREATS
      object: Wilson's disease
    - subject: laparoscopic cholecystectomy
      predicate: PREVENTS
      object: symptomatic gallstone disease
      qualifier: MONDO:0010200
named_entities:
  - id: MONDO:0010200
    label: Wilson's disease
  - id: MAXO:0001175
    label: Liver transplantation
  - id: HP:0001695
    label: Cardiac arrest
  - id: HP:0001685
    label: Myocardial fibrosis
  - id: HP:0001663
    label: Ventricular fibrillation
  - id: CHEBI:28694
    label: Copper
  - id: CHEBI:18248
    label: Iron
  - id: HP:0002910
    label: abnormal liver functions
  - id: HP:0001394
    label: cirrhosis
  - id: CHEBI:27363
    label: zinc
  - id: CHEBI:50868
    label: penicillamine
  - id: MAXO:0000016
    label: Cell therapy
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:30703
    label: Tetrathiomolybdate (TTM)
  - id: HP:0006554
    label: acute liver failure
  - id: CHEBI:35176
    label: Zinc sulphate
  - id: CHEBI:35475
    label: NSAIDs
  - id: MAXO:0009095
    label: zinc therapy
  - id: MAXO:0001298
    label: therapy
  - id: HP:0006579
    label: neonatal jaundice
  - id: HP:0001409
    label: portal hypertension
  - id: HP:0030151
    label: cholangitis
  - id: HP:0002612
    label: congenital hepatic fibrosis
  - id: MONDO:0013282
    label: alpha-1-antitrypsin deficiency
  - id: HP:0001903
    label: anemia
  - id: HP:0001410
    label: liver dysfunction
  - id: CHEBI:39501
    label: trientine
  - id: MAXO:0000070
    label: Hepatic transplantation
  - id: HP:0001399
    label: Hepatic failure
  - id: HP:0004448
    label: fulminant hepatic failure
  - id: HP:0003256
    label: coagulopathy (international normalized ratio >2.0)
  - id: HP:0004445
    label: hepatic encephalopathy (HE)
  - id: HP:0002480
    label: hepatic encephalopathy
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:33281
    label: Antibiotics
  - id: MONDO:0100193
    label: End-stage liver disease
  - id: HP:0100626
    label: End-stage liver disease
  - id: HP:0100660
    label: dyskinesia
  - id: HP:0100022
    label: Movement disorders
  - id: HP:0001337
    label: Tremor
  - id: HP:0001332
    label: Dystonia
  - id: MONDO:0019542
    label: Acute liver failure (ALF)
  - id: CHEBI:27385
    label: CCL4
  - id: MAXO:0000127
    label: Genetic testing
  - id: CHEBI:7959
    label: D-penicillamine
  - id: MAXO:0001017
    label: Vaccination
  - id: HP:0001541
    label: Ascites
  - id: HP:0012398
    label: Peripheral edema
  - id: HP:0001260
    label: dysarthria
  - id: HP:0000708
    label: psychiatric disorders
  - id: HP:0200123
    label: chronic hepatitis
  - id: CHEBI:38161
    label: chelators
  - id: MAXO:0000376
    label: liver biopsy
  - id: HP:0001404
    label: hepatocellular necrosis
  - id: CHEBI:61049
    label: Tacrolimus
  - id: HP:0001744
    label: Splenomegaly
  - id: MAXO:0000603
    label: Peritoneal dialysis
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: HP:0002172
    label: impaired balance
  - id: HP:0001347
    label: hyperreflexia
  - id: HP:0031843
    label: bradyphrenia
  - id: HP:0002362
    label: shuffling gait
  - id: HP:0001621
    label: hypophonia
  - id: CHEBI:37153
    label: Calcineurin inhibitors
  - id: CHEBI:8356
    label: pramipexole
  - id: CHEBI:2618
    label: amantadine
  - id: HP:0000093
    label: proteinuria
  - id: CHEBI:231592
    label: zinc salts
  - id: MAXO:0000167
    label: antiepileptic therapy
  - id: CHEBI:9168
    label: rapamycin
  - id: CHEBI:55379
    label: cyclosporine (CsA)
  - id: CHEBI:35623
    label: antiepileptic
  - id: HP:0000083
    label: renal failure
